Clinical Trial Update: RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing immune response to an RSV vaccine in recipients of stem cell transplantation and CAR-T therapy, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV vaccine (respiratory syncytial virus vaccine)

Snippet

Sponsor: The Cooper Health System | Conditions: CAR-T Cell Therapy, RSV Immunization | Phase 4 | Status: NOT_YET_RECRUITING